These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9635707)

  • 1. Acute treatment-related diarrhea during postoperative adjuvant therapy for high-risk rectal carcinoma.
    Miller RC; Martenson JA; Sargent DJ; Kahn MJ; Krook JE
    Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):593-8. PubMed ID: 9635707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute diarrhea during adjuvant therapy for rectal cancer: a detailed analysis from a randomized intergroup trial.
    Miller RC; Sargent DJ; Martenson JA; Macdonald JS; Haller D; Mayer RJ; Gunderson LL; Rich TA; Cha SS; O'Connell MJ
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):409-13. PubMed ID: 12243815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94.
    Sauer R; Fietkau R; Wittekind C; Rödel C; Martus P; Hohenberger W; Tschmelitsch J; Sabitzer H; Karstens JH; Becker H; Hess C; Raab R;
    Colorectal Dis; 2003 Sep; 5(5):406-15. PubMed ID: 12925071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94).
    Sauer R; Fietkau R; Wittekind C; Martus P; Rödel C; Hohenberger W; Jatzko G; Sabitzer H; Karstens JH; Becker H; Hess C; Raab R
    Strahlenther Onkol; 2001 Apr; 177(4):173-81. PubMed ID: 11370551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The acute toxicity of the simultaneous radiochemotherapy of rectal carcinoma].
    Rödel C; Fietkau R; Keilholz L; Grabenbauer GG; Kessler H; Martus P; Sauer R
    Strahlenther Onkol; 1997 Aug; 173(8):415-21. PubMed ID: 9289858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response.
    Mohiuddin M; Regine WF; John WJ; Hagihara PF; McGrath PC; Kenady DE; Marks G
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):883-8. PubMed ID: 10705009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114.
    Tepper JE; O'Connell MJ; Petroni GR; Hollis D; Cooke E; Benson AB; Cummings B; Gunderson LL; Macdonald JS; Martenson JA
    J Clin Oncol; 1997 May; 15(5):2030-9. PubMed ID: 9164215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant postoperative 5-fluorouracil chemotherapy combined with pelvic radiation for rectal cancer: results from an Asian population.
    Au E; Koo WH; Lee KS; Chua EJ; Soo KC; Seow-Choen F; Low CH; Ng BK; Hoe M
    Cancer Invest; 2001; 19(4):340-5. PubMed ID: 11405173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the comparative toxicity of 5-FU bolus versus 5-FU continuous infusion circadian chemotherapy with concurrent radiation therapy in locally advanced rectal cancer.
    Thrall MM; Wood P; King V; Rivera W; Hrushesky W
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):873-81. PubMed ID: 10705008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
    Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of 5-fluorouracil and leucovorin by continuous infusion chronotherapy and pelvic radiotherapy in patients with locally advanced or recurrent rectal cancer.
    Parulekar W; de Marsh RW; Wong R; Mendenhall W; Davey P; Zlotecki R; Berry S; Rout WR; Bjarnason GA
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1487-95. PubMed ID: 15050328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raltitrexed and radiotherapy as adjuvant treatment for stage II-III rectal cancer: a feasibility study.
    Lupattelli M; Maranzano E; Bellavita R; Natalini G; Corgna E; Rossetti R; Trippa F; Mascioni F; Sidoni A; Anselmo P; Buzzi F; Brugia M; Latini P
    Tumori; 2005; 91(6):498-504. PubMed ID: 16457149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting grade 3 acute diarrhea during radiation therapy for rectal cancer using a cutoff-dose logistic regression normal tissue complication probability model.
    Robertson JM; Söhn M; Yan D
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):66-72. PubMed ID: 19665323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
    Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phase I study of postoperative concurrent chemoradiation with capecitabine as adjuvant treatment for stage II/III operable rectal cancer].
    Jin J; Li YX; Liu YP; Wang WH; Li T; Li N; Song YW
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):393-6. PubMed ID: 17045010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment.
    Sanfilippo NJ; Crane CH; Skibber J; Feig B; Abbruzzese JL; Curley S; Vauthey JN; Ellis LM; Hoff P; Wolff RA; Brown TD; Cleary K; Wong A; Phan T; Janjan NA
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):176-83. PubMed ID: 11516868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: a Phase II trial for the Trans-Tasman Radiation Oncology Group.
    Ngan SY; Burmeister BH; Fisher R; Rischin D; Schache DJ; Kneebone A; MacKay JR; Joseph D; Bell A; Goldstein D
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):883-7. PubMed ID: 11429215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant radiochemotherapy in high-risk rectal cancer results of a prospective non-randomized study.
    Lupattelli M; Maranzano E; Bellavita R; Tarducci R; Latini R; Castagnoli P; Bufalari A; Corgna E; Pinaglia D; Rossetti R; Ribacchi R; Latini P
    Tumori; 2001; 87(4):239-47. PubMed ID: 11693802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group.
    Tveit KM; Guldvog I; Hagen S; Trondsen E; Harbitz T; Nygaard K; Nilsen JB; Wist E; Hannisdal E
    Br J Surg; 1997 Aug; 84(8):1130-5. PubMed ID: 9278661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.